AMICULUM® is an independent global health communications and consultancy business that works with pharmaceutical, biotechnology and health technology companies across the world. Our specialist services include medical communications, healthcare learning, creative design, clinical and commercial consultancy, support for market access and digital engagement.  AMICULUM supports products in a wide range of therapy areas and has teams that focus specifically on rare diseases and advances in genomic medicine. 

Created in 2001, AMICULUM has grown steadily for the past 21 years and now employs over 330 people worldwide. We have teams based across multiple locations in New Zealand, China, Hong Kong, Singapore, UAE, Switzerland, UK and USA. We have a team based on the campus of the University of Dundee.